Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels

Clin Chem Lab Med. 2013 Dec;51(12):e287-9. doi: 10.1515/cclm-2013-0461.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adalimumab
  • Antibodies / blood*
  • Antibodies / immunology*
  • Antibodies, Monoclonal / blood*
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal, Humanized / blood*
  • Antibodies, Monoclonal, Humanized / immunology
  • Enzyme-Linked Immunosorbent Assay
  • Etanercept
  • Humans
  • Immunoglobulin G / blood*
  • Immunoglobulin G / immunology
  • Infliximab
  • Reagent Kits, Diagnostic
  • Receptors, Tumor Necrosis Factor / blood*
  • Receptors, Tumor Necrosis Factor / immunology

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Reagent Kits, Diagnostic
  • Receptors, Tumor Necrosis Factor
  • Infliximab
  • Adalimumab
  • Etanercept